AARTIPHARM
AARTI PHARMALABS LIMITEDHealthcare
LTP
938.95
CHG · %
+55.2 (+6.25%)
VOL · TODAY
27.36L
PREV CLOSE
883.75
Today's range885 · 957.3
938.95
52-week range585 · 957.3
938.95
Loading candles…
Aarti Pharmalabs Ltd was incorporated in 2019 through a demerger from Aarti Industries Limited. The company operates in the pharmaceuticals and nutraceuticals industries, specializing in the manufacturing of active pharmaceutical ingredients (APIs), advanced intermediates, xanthine derivatives, pharmaceuticals, and nutraceuticals. It provides end-to-end solutions from process development to commercial manufacturing. Aarti Pharmalabs maintains a strong global presence with exports to regulated markets including India, the United States, the European Union, and Japan. The company is recognized as a key player in the 'China+1' strategy, utilizing fully backward-integrated manufacturing processes to enhance supply chain resilience.
AARTIPHARM is not part of any active scan today.
This page is a live market overview for AARTI PHARMALABS LIMITED (AARTIPHARM) on the NSE. As a listed security, AARTI PHARMALABS LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for AARTIPHARM before placing trades on tick2trade.
As of the latest feed, AARTIPHARM last traded at ₹938.95 on NSE, up ₹55.2 (6.25%) from the previous close of ₹883.75. Today's session range is ₹885 – ₹957.3, against a 52-week band of ₹585 – ₹957.3. Traded volume today stands at 27.36L shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for AARTIPHARM in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether AARTIPHARM is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for AARTI PHARMALABS LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in AARTIPHARM. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated AARTIPHARM option chain page linked from this overview.
// similar in healthcare323 total